ALSTODT LANCE 4
4 · BioRestorative Therapies, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
ALSTODT LANCE
DirectorPresident, CEO, COB
Transactions
- Award
Stock Option
2025-02-14+791,885→ 791,885 totalExercise: $2.46Exp: 2035-02-14→ Common Stock (791,885 underlying)
Holdings
- 171,872
Common Stock
- 293,479
Stock Option
Exercise: $5.08Exp: 2031-03-18→ Common Stock (293,479 underlying) - 42,059
Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (42,059 underlying) - 106,762
Stock Option
Exercise: $2.91Exp: 2033-02-17→ Common Stock (106,762 underlying) - 438,596
Stock Option
Exercise: $1.45Exp: 2034-02-13→ Common Stock (438,596 underlying)
Footnotes (4)
- [F1]The option is currently exercisable.
- [F2]The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.
- [F3]The option vests and becomes exercisable to the extent of 219,298 shares on February 13, 2024 and 219,298 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested.
- [F4]The options vests and becomes exercisable to the extent of 395,943 shares on February 14, 2025 and 395,942 shares in eight nearly equal quarterly installments beginning February 14, 2026 and continuing every three months thereafter until fully vested.